LC–ESI–MS/MS analysis, combining high-performance liquid chromatography resolution with mass spectrometer accuracy, detected elevated levels of EMILIN-1 peptides among other plasma proteins in breast cancer patients [50]. Here, EMILIN1 is linked to breast cancer.